NASDAQ:HCTI - Nasdaq - US42227W2070 - Common Stock - Currency: USD
0.395
-0.11 (-21.47%)
The current stock price of HCTI is 0.395 USD. In the past month the price decreased by -54.56%. In the past year, price decreased by -79.32%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
SDGR | SCHRODINGER INC | N/A | 1.65B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. The company is headquartered in Pleasanton, California and currently employs 33 full-time employees. The company went IPO on 2021-10-01. The firm is focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record (EHR), healthcare and life sciences industries. The firm operates through three segments: Software Services, Managed Services and Support, and Platform Services. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment include post implementation support and cloud hosting. Its Platform Services segment includes CloudEz, DataEz, and Readabl.AI platforms. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical and Life Sciences, biotech companies, and medical device manufacturers in their efforts to improve data management.
HEALTHCARE TRIANGLE INC
4309 Hacienda Dr., Suite 150
Pleasanton CALIFORNIA US
CEO: Joseph Kristul
Employees: 22
Company Website: https://www.healthcaretriangle.com/
Investor Relations: https://www.healthcaretriangle.com/investors/
Phone: 19252704812
The current stock price of HCTI is 0.395 USD. The price decreased by -21.47% in the last trading session.
The exchange symbol of HEALTHCARE TRIANGLE INC is HCTI and it is listed on the Nasdaq exchange.
HCTI stock is listed on the Nasdaq exchange.
HEALTHCARE TRIANGLE INC (HCTI) has a market capitalization of 2.24M USD. This makes HCTI a Nano Cap stock.
HEALTHCARE TRIANGLE INC (HCTI) currently has 22 employees.
HEALTHCARE TRIANGLE INC (HCTI) has a resistance level at 0.61. Check the full technical report for a detailed analysis of HCTI support and resistance levels.
The Revenue of HEALTHCARE TRIANGLE INC (HCTI) is expected to grow by 9.66% in the next year. Check the estimates tab for more information on the HCTI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HCTI does not pay a dividend.
HEALTHCARE TRIANGLE INC (HCTI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.18).
The outstanding short interest for HEALTHCARE TRIANGLE INC (HCTI) is 1.76% of its float. Check the ownership tab for more information on the HCTI short interest.
ChartMill assigns a fundamental rating of 1 / 10 to HCTI. HCTI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months HCTI reported a non-GAAP Earnings per Share(EPS) of -2.18. The EPS increased by 24.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -208.83% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to HCTI. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 25% and a revenue growth 9.66% for HCTI